The impact of homocysteine-lowering therapy on cardiovascular outcomes: An updated meta-analysis of 13 trials

被引：0
|
作者：
Das, Jayanta [1 ]
Diamond, George A. [1 ]
Eshaghian, Shervin [1 ]
Amin, Sameer [1 ]
Shah, Prediman K. [1 ]
Kaul, Sanjay [1 ]
机构：
[1] Cedars Sinai Med Ctr, Los Angeles, CA 90048 USA
来源：
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY | 2008年 / 51卷 / 10期
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：A248 / A248
页数：1
相关论文
共 50 条
  • [1] Homocysteine-lowering therapy does not lead to reduction in cardiovascular outcomes in chronic kidney disease patients: a meta-analysis of randomised, controlled trials
    Pan, Yu
    Guo, Li Li
    Cai, Ling Ling
    Zhu, Xiao Juan
    Shu, Jin Lian
    Liu, Xiao Li
    Jin, Hui Min
    [J]. BRITISH JOURNAL OF NUTRITION, 2012, 108 (03) : 400 - 407
  • [2] Homocysteine-lowering trials for prevention of vascular disease: protocol for a collaborative meta-analysis
    Clarke, R.
    Armitage, J.
    Lewington, S.
    Collins, R.
    [J]. CLINICAL CHEMISTRY AND LABORATORY MEDICINE, 2007, 45 (12) : 1575 - 1581
  • [3] Homocysteine-lowering therapy with folic acid is effective in cardiovascular disease prevention in patients with kidney disease: A meta-analysis of randomized controlled trials
    Qin, Xianhui
    Huo, Yong
    Xie, Di
    Hou, Fanfan
    Xu, Xiping
    Wang, Xiaobin
    [J]. CLINICAL NUTRITION, 2013, 32 (05) : 722 - 727
  • [4] Efficacy of Homocysteine-Lowering Therapy With Folic Acid in Stroke Prevention A Meta-Analysis
    Lee, Meng
    Hong, Keun-Sik
    Chang, Shen-Chih
    Saver, Jeffrey L.
    [J]. STROKE, 2010, 41 (06) : 1205 - 1212
  • [5] Does homocysteine lowering impact cardiovascular outcomes? A Bayesian meta-analysis of NORVIT and HOPE-2 trials
    Kaul, Sanjay
    Zadeh, Andrew A.
    Diamond, George A.
    Shah, Prediman K.
    [J]. CIRCULATION, 2006, 114 (18) : 906 - 907
  • [6] Homocysteine-Lowering Treatment and the Risk of Fracture: Secondary Analysis of a Randomized Controlled Trial and an Updated Meta-Analysis
    Lopez, Maria Garcia
    Baron, John A.
    Omsland, Tone K.
    Sogaard, Anne Johanne
    Meyer, Haakon E.
    [J]. JBMR PLUS, 2018, 2 (05) : 295 - 303
  • [7] Homocysteine-lowering B vitamin therapy in cardiovascular prevention - Wrong again?
    Lonn, Eva
    [J]. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 2008, 299 (17): : 2086 - 2087
  • [8] Homocysteine-lowering trials for prevention of cardiovascular events: A review of the design and power of the large randomized trials
    Clarke, R
    Armitage, J
    Lewington, S
    Sherliker, P
    Collins, R
    Brown, M
    Blackwood, S
    Bostom, A
    Loan, E
    Yusuf, S
    Genest, J
    Bonaa, K
    Njolstad, I
    Mennen, L
    Galan, P
    Hercberg, S
    Jamison, R
    Gaziano, JM
    Hartigan, P
    Hankey, G
    Eikelboom, J
    Toole, J
    Malinow, MR
    Chambless, LE
    Spence, JD
    Pettigrew, L
    Howard, VJ
    Sides, EG
    Wang, CH
    Stampfer, M
    Manson, JE
    Nygard, O
    Nordrehaug, JE
    Nilsen, DWT
    Refsum, H
    Ueland, PM
    Vollset, SE
    [J]. AMERICAN HEART JOURNAL, 2006, 151 (02) : 282 - 287
  • [9] The Impact of Cell Therapy on Cardiovascular Outcomes in Patients With Refractory Angina An Updated Systematic Review and Meta-Analysis of Randomized Controlled Trials
    Jones, Daniel A.
    Weeraman, Deshan
    Colicchia, Martina
    Hussain, Mohsin A.
    Veerapen, Devanayegi
    Andiapen, Mervyn
    Rathod, Krishnaraj S.
    Baumbach, Andreas
    Mathur, Anthony
    [J]. CIRCULATION RESEARCH, 2019, 124 (12) : 1786 - 1795
  • [10] Vitamin supplements and cardiovascular risk: Review of the randomized trials of homocysteine-lowering vitamin supplements
    Clarke, R
    Armitage, J
    [J]. SEMINARS IN THROMBOSIS AND HEMOSTASIS, 2000, 26 (03): : 341 - 348
12345